U.S. Logistics Stock News

Karooooo (NasdaqCM:KARO) opened Q1 2027 with revenue of ZAR1.6b and basic EPS of ZAR9.53, setting a clear benchmark for how the company is currently converting its top line into per share earnings. Over recent periods, the company has reported revenue of ZAR1.3b in Q1 2026 and ZAR1.6b in Q1 2027, while basic EPS has ranged from ZAR8.55 in Q1 2026 to ZAR9.53 in the latest quarter. This gives investors a clear view of how revenue and per share earnings have moved together. With margins now in...

Monster Beverage stock has delivered a strong 114.1% total return over the past five years, and today both the market price and valuation checks point to the shares trading at a premium rather than at a discount to intrinsic value. Over five years, Monster Beverage has returned 114.1%, which means anyone holding through that period has already seen substantial gains baked into the current share price. Investors are weighing strong recent sales momentum and a planned 2-for-1 stock split...

QuidelOrtho (QDEL) is back in focus after filing a shelf registration for up to 1,000,000 shares of common stock. This ESOP-related move puts potential equity issuance on investors' radar. See our latest analysis for QuidelOrtho. At a share price of US$18.24, QuidelOrtho has seen a 30-day share price return of 29.18% and a 90-day share price return of 43.51%, yet the year-to-date share price return is down 36.62% and the 3-year total shareholder return has declined 78.49%. This suggests that...

American Water Works Company recently secured over US$64 million in PENNVEST grants and low‑interest loans for Pennsylvania system upgrades, while outlining a US$48.00 billion, decade‑long water and wastewater infrastructure investment program focused on renewal, water quality, resiliency, technology, and acquisitions. Together with industry awards, wildfire‑risk mitigation and workforce initiatives, this funding and long-horizon capital plan underline how deeply American Water is tying...

After an 89.0% total return over the past five years, Webster Financial now sits around US$76, raising a clear valuation question: the Excess Returns intrinsic value model points to meaningful upside, while the broader checks suggest the stock is not an obvious bargain or a clear outlier. Webster Financial has delivered 89.0% over five years, which puts current buyers in the position of judging whether a strong run has already captured most of the available upside. Future revenue and profit...

Yum! Brands stock has returned 38.9% over the past five years, and after that steady climb the current market price around US$152 now sits close to what a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples both suggest is a roughly fair valuation, even as fresh food safety headlines put its risk profile under closer scrutiny. A 38.9% gain over five years points to solid long term shareholder returns that now look more in line with a mature, fairly valued consumer...

In recent months, Newmark Group arranged a US$515 million fixed-rate refinancing for the 785,000-square-foot Class A office tower at 31 West 52nd Street in Midtown Manhattan, while also advising Rithm Capital on its broader US$1.60 billions Paramount portfolio acquisition. This pairing of a large Manhattan refinancing and a multi-billions portfolio mandate spotlights how Rithm Capital is managing capital deployment and funding across complex real estate transactions. We’ll now examine how...

Cummins (CMI) is back in focus after its Board approved a 10% increase in the quarterly dividend to $2.20 per share, a move that highlights management’s stance on shareholder returns and cash generation. See our latest analysis for Cummins. Despite the dividend increase and upbeat earnings expectations, Cummins’ share price has recently eased, with a 1-month share price return of down 7.45% following a strong year to date share price return of 24.10% and a 1-year total shareholder return of...

Marvell Technology's share price has delivered a very large 5 year gain, yet its recent pullback and low value score raise questions about how much upside may still be reflected in the current valuation. Over the past 5 years, Marvell Technology has returned about 230.9%, which puts extra focus on whether the current price still lines up with fundamentals. Investor expectations for Marvell Technology's role in custom AI and networking chips can support a premium, while sector wide swings...

Earlier this month, Columbia Banking System reached a fresh yearly high as investors responded to stronger earnings momentum, steady deposits, and consistent dividend payments despite ongoing sector challenges. The combination of robust credit discipline and effective operating scale appears to be reinforcing confidence in the bank's ability to manage economic sensitivity and funding competition. Building on this renewed confidence and earnings momentum, we'll examine how the latest results...

Recently, Zacks assigned ZTO Express (Cayman) a Rank #1 (Strong Buy), highlighting an improved earnings outlook versus peer C.H. Robinson Worldwide, supported by ZTO’s lower forward P/E ratio of 11.80 and PEG ratio of 0.87. This combination of a top analyst ranking and comparatively cheaper valuation metrics has drawn attention to ZTO as a potentially more compelling value option within the logistics space. Now we will examine how ZTO’s upgraded ranking and relative valuation advantage might...

Multiple U.S. states have escalated their antitrust fight against the proposed Paramount and Warner Bros. Discovery merger, with 12 states filing lawsuits to block the deal. A separate Paramount shareholder lawsuit alleges David and Larry Ellison arranged an illegal side agreement with a former U.S. president to secure regulatory approval. These actions raise fresh regulatory, legal, and reputational questions for Warner Bros. Discovery, ticker NasdaqGS:WBD, and could affect the outcome of...

NorthWestern Energy Group (NWE) has filed a Pre Inspection Preparation Report with the Federal Energy Regulatory Commission for the Thompson Falls Project, ahead of its thirteenth scheduled safety inspection in August 2026. See our latest analysis for NorthWestern Energy Group. At a share price of $73.27, NorthWestern Energy Group has seen momentum build recently, with a 7 day share price return of 3.44% and a year to date share price return of 13.16%. The 1 year total shareholder return of...

Abbott Laboratories (ABT) is back in focus after second quarter 2026 earnings topped market expectations, powered by Medical Devices and Diagnostics, and a higher full year adjusted EPS outlook lifted the stock sharply. See our latest analysis for Abbott Laboratories. The latest results have triggered a sharp 1 day share price return of 10.71% and lifted Abbott Laboratories to US$98.83, yet the year to date share price return is still down 20.42% and the 1 year total shareholder return is...

Deere (DE) is back in focus after agreeing with the Federal Trade Commission and five states to broaden farmers' access to equipment repair tools, closing a regulatory matter and clarifying its approach to equipment maintenance. See our latest analysis for Deere. At a share price of $598.97, Deere has delivered a 28.31% year to date share price return, alongside a 21.50% total shareholder return over 1 year and 82.07% over 5 years. This suggests momentum has been building around the stock...

In recent commentary, HNI’s 9.3% annual earnings per share growth trailing revenue, absence of free cash flow, and net-debt-to-EBITDA of 6x have raised concerns about its ability to reinvest or return capital to shareholders. This combination of limited cash generation, elevated leverage, and a relatively low forward valuation is prompting investors to reassess the company’s overall risk profile and financial flexibility. We’ll now examine how concerns about HNI’s high net-debt-to-EBITDA...

CVS Health stock has delivered a strong 74.4% return over the past year, yet its valuation checks lean expensive and suggest the current share price may already be pricing in a lot of good news. A 74.4% one year gain can signal renewed confidence in CVS Health, but it also raises the bar for what future performance needs to justify the current price. Regulatory settlements around insulin pricing and Omnicare, along with ongoing legal and compliance obligations, may affect how investors...

Teladoc Health (TDOC) is back in focus after fresh analyst commentary highlighted concerns around flat sales, falling revenue per user, and a business model geared more toward user growth than monetization, as the next earnings date approaches. See our latest analysis for Teladoc Health. Against this cautious backdrop, Teladoc Health’s share price has climbed to $9.47, with a 30 day share price return of 25.10% and a 90 day gain of 66.43%, while the 3 year total shareholder return is down...

Sprouts Farmers Market (SFM) is drawing fresh attention after giving LivReal, a fruit flavored energy drink made from real squeezed fruit, nationwide placement in its Innovation Set program, supported by extensive in store marketing. See our latest analysis for Sprouts Farmers Market. Despite the LivReal rollout and other recent product initiatives, Sprouts Farmers Market’s share price has eased, with a 7 day share price return of 8.35% and a 30 day share price return of 11.89%. The 1 year...

Earlier this week, DaVita highlighted that it is heading into its Q2 FY2026 earnings report with stronger treatment volumes and productivity gains, leading management to raise adjusted operating income and EPS guidance. This combination of improving operational metrics and higher guidance suggests investors are watching closely how sustained efficiency improvements could influence DaVita’s longer-term earnings profile. Next, we’ll explore how DaVita’s upgraded adjusted operating income and...

In the past few days, MP Materials reported Q1 2026 results showing year-over-year revenue growth and better-than-expected adjusted earnings, while confirming strong liquidity to fund its capital-intensive rare earth and magnet projects. The company’s continued pivot from rare earth concentrate sales to higher-value domestic magnet production, supported by U.S. government agreements, is steadily reshaping its role in the critical materials supply chain. We’ll now examine how MP Materials’...

Founder led companies can appeal when inflation, interest rates and growth signals are pulling in different directions, because leadership is often financially and reputationally tied to long term outcomes. With central banks adjusting policy, bond yields shifting and trade and energy trends in focus, many investors are looking for businesses where decision makers have real skin in the game. This Founder Led Companies screener aims to surface stocks where leadership is closely aligned with...

Amneal Pharmaceuticals (AMRX) is back in focus after a recent review highlighted strong long term shareholder returns, alongside slower projected revenue growth, stagnant free cash flow margins, and mixed outcomes from past growth initiatives. See our latest analysis for Amneal Pharmaceuticals. At a share price of $18.04, Amneal Pharmaceuticals has seen strong short term momentum, with a 30 day share price return of 11.02% and year to date share price return of 42.50%, on top of a 1 year...

With inflation trends mixed, bond yields moving in different directions across regions, and energy prices influenced by supply tensions, investors are paying closer attention to what really underpins a stock: its cash generation. The Undervalued Stocks Based On Cash Flows screener focuses on companies where discounted cash flow estimates from SWS suggest the share price does not fully reflect their cash flow potential. For readers looking for ideas grounded in fundamentals rather than...